Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Measurement of base substitution induced by adenine base editor
应用场景：
创建时间：
2018-04-19
相关数据集
Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas based technology. Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas based technology
Cornelia de Lange syndrome (CdLS) is an autosomal dominant disease mainly caused by mutations in the Nipped-B-like protein (NIPBL) gene resulting in the alteration of the cohesin pathway. Here, we gen
NIAID Data Ecosystem90
Highly Efficient Gene editing of SaCas9 and AsCas12a in Patient-Derived Hematopoietic Stem and Progenitor Cells for Treating Sickle Cell Disease
GUIDE-seq, CAST-seq, and LongAmp-seq fastq files for targeting HBB, HBG promoter, and BCL11A erythroid enhancer with SpCas9, SaCas9, and AsCas12
NIAID Data Ecosystem50
Data from glucose metabolism array.
Genetic compensation is a common phenomenon in zebrafish in response to genetic alterations. Differences between genetic and morpholino-mediated zebrafish models of human diseases have led to signific
Figshare2026-01-14 更新30
Treatment of a metabolic liver disease by in vivo prime editing in mice. Treatment of a metabolic liver disease by in vivo prime editing in mice
Prime editing is a highly versatile CRISPR-based genome editing technology with the potential to correct the vast majority of genetic defects1. However, correction of a disease phenotype in vivo in so
NIAID Data Ecosystem70
in vivo NGS data for "Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles "
Set of in vivo samples for publication: "Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles " by Degtev et al in Nature Communications
NIAID Data Ecosystem30
